Efficacy of hepatitis B vaccine wanes with time

Vaccination News Home Page

http://bmj.com/cgi/content/full/325/7364/0/a

BMJ Intended for Health Professionals in the US with an interest in Smoking Cessation
 

Home Help Search/Archive Feedback Table of Contents

Efficacy of hepatitis B vaccine wanes with time

The efficacy of hepatitis vaccination in infancy in a highly endemic country wanes with time, but efficacy against chronic infection remains high over 14 years. Whittle and colleagues (p 569) measured vaccine efficacy in 172 children and teenagers in a Gambian village who had been immunised against hepatitis B in infancy. Efficacy of the vaccine against infection was 65%. Against chronic carriage efficacy was 88%. The authors say that due to the small numbers in the study a larger study of efficacy during adolescence is needed to decide whether a booster dose of hepatitis B vaccine is necessary in teenagers.

 
(Credit: WHO)





 

 

Home Help Search/Archive Feedback Table of Contents

BMJ
 

Vaccination News Home Page

ALL INFORMATION, DATA, AND MATERIAL CONTAINED, PRESENTED, OR PROVIDED HERE IS FOR GENERAL INFORMATION PURPOSES ONLY AND IS NOT TO BE CONSTRUED AS REFLECTING THE KNOWLEDGE OR OPINIONS OF THE PUBLISHER, AND IS NOT TO BE CONSTRUED OR INTENDED AS PROVIDING MEDICAL OR LEGAL ADVICE.  THE DECISION WHETHER OR NOT TO VACCINATE IS AN IMPORTANT AND COMPLEX ISSUE AND SHOULD BE MADE BY YOU, AND YOU ALONE, IN CONSULTATION WITH YOUR HEALTH CARE PROVIDER.